CD8A and myeloid sarcoma: Interestingly, studies investigating anti-EBV immunity in the CNS of MS patients suggest that EBV-specific T cells can gain access to the brain and that altered intrathecal CD8 T cell responses toward EBV could contribute to CNS inflammation and tissue damage [18].